<DOC>
	<DOCNO>NCT00003864</DOCNO>
	<brief_summary>RATIONALE : Drugs use chemotherapy use different way stop cancer cell divide stop grow die . Combining one drug may kill cancer cell . PURPOSE : Phase II trial study effectiveness docetaxel plus carboplatin treating patient advance cancer esophagus .</brief_summary>
	<brief_title>Docetaxel Plus Carboplatin Treating Patients With Advanced Cancer Esophagus</brief_title>
	<detailed_description>OBJECTIVES : I . Evaluate objective response rate patient advance squamous cell carcinoma esophagus treat carboplatin docetaxel . II . Assess toxicity regimen patient . III . Assess time progression overall survival patient population . OUTLINE : Patients receive docetaxel IV 1 hour day 1 , follow carboplatin IV 15-30 minute day 1 . Treatment repeat every 3 week 6 course absence disease progression unacceptable toxicity . Patients follow every 3 month year 2 , every 6 month year 2-5 , annually thereafter death . PROJECTED ACCRUAL : A total 18-35 patient accrue study rate 30 patient per year .</detailed_description>
	<mesh_term>Esophageal Neoplasms</mesh_term>
	<mesh_term>Docetaxel</mesh_term>
	<mesh_term>Carboplatin</mesh_term>
	<criteria>DISEASE CHARACTERISTICS : Histologically confirm metastatic incurable , locally advance squamous cell carcinoma esophagus Measurable disease outside previously radiated field require PATIENT CHARACTERISTICS : Age : 18 Performance status : ECOG 02 Life expectancy : Not specify Hematopoietic : Absolute granulocyte count least 1500/mm3 Platelet count least 100,000/mm3 Hepatic : Bilirubin normal SGOT great 2 time upper limit normal Renal : Creatinine normal Cardiovascular : No congestive heart failure angina pectoris , even medically control No prior myocardial infarction within past year No clinically significant conduction system abnormality , 2nd 3rd degree heart block bundle branch block Pulmonary : Not specify Other : Not pregnant nursing Fertile patient must use effective contraception No active infection medical illness uncontrolled No second malignancy previously treat nonmelanoma skin cancer carcinoma situ cervix prior malignancy patient disease free past 3 year Caloric intake great 1500 calories/day Fluid intake great 1500 mL/day PRIOR CONCURRENT THERAPY : Biologic therapy : Not specify Chemotherapy : No prior chemotherapy Endocrine therapy : Not specify Radiotherapy : At least 4 week since prior radiotherapy Surgery : Not specify</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>August 2013</verification_date>
	<keyword>stage III esophageal cancer</keyword>
	<keyword>stage IV esophageal cancer</keyword>
	<keyword>squamous cell carcinoma esophagus</keyword>
</DOC>